This inventor holds 3 USPTO granted patents. Top assignees: Amrad Corporation Limited, Walter and Eliza Hall Institute of Medical Research. Active years: 1997-2003.
Company Filing History:
2 out of 33 
1 out of 84 
Years Active: 1997-2003
Title: Larry David Ward: Innovator in Receptor-Type Tyrosine Kinase Research
Introduction
Larry David Ward is an accomplished inventor based in Balaclava, Australia. He has made significant contributions to the field of receptor-type tyrosine kinases, holding a total of 3 patents. His work has implications in various medical and biotechnological applications.
Latest Patents
Ward's latest patents include a method for screening for soluble ligands to a receptor-type tyrosine kinase. This invention relates to a method of identifying ligands that interact with a receptor-type tyrosine kinase, characterized by its reactivity to monoclonal antibody III.A4 and a molecular weight of approximately 120-150 kD in its glycosylated form. Another notable patent is for an isolated receptor-type tyrosine kinase, which shares similar characteristics and potential applications in research and therapy.
Career Highlights
Throughout his career, Larry David Ward has worked with prominent organizations such as Amrad Corporation Limited and the Walter and Eliza Hall Institute of Medical Research. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Some of his notable coworkers include Andrew W Boyd and Richard John Simpson. Their collaborative efforts have further enriched the research landscape in which Ward operates.
Conclusion
Larry David Ward's innovative work in receptor-type tyrosine kinases has positioned him as a key figure in his field. His patents and collaborations reflect his commitment to advancing medical research and technology.